These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35528817)

  • 41. Epidemiology & molecular biology of Vibrio cholerae O139 Bengal.
    Albert MJ
    Indian J Med Res; 1996 Jul; 104():14-27. PubMed ID: 8783504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A live vaccine rapidly protects against cholera in an infant rabbit model.
    Hubbard TP; Billings G; Dörr T; Sit B; Warr AR; Kuehl CJ; Kim M; Delgado F; Mekalanos JJ; Lewnard JA; Waldor MK
    Sci Transl Med; 2018 Jun; 10(445):. PubMed ID: 29899024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Type III secretion is essential for the rapidly fatal diarrheal disease caused by non-O1, non-O139 Vibrio cholerae.
    Shin OS; Tam VC; Suzuki M; Ritchie JM; Bronson RT; Waldor MK; Mekalanos JJ
    mBio; 2011; 2(3):e00106-11. PubMed ID: 21673189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Designing an efficient multi-epitope peptide vaccine against Vibrio cholerae via combined immunoinformatics and protein interaction based approaches.
    Nezafat N; Karimi Z; Eslami M; Mohkam M; Zandian S; Ghasemi Y
    Comput Biol Chem; 2016 Jun; 62():82-95. PubMed ID: 27107181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
    Haney DJ; Lock MD; Gurwith M; Simon JK; Ishioka G; Cohen MB; Kirkpatrick BD; Lyon CE; Chen WH; Sztein MB; Levine MM; Harris JB
    Vaccine; 2018 May; 36(20):2768-2773. PubMed ID: 29655627
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1.
    Kenner JR; Coster TS; Taylor DN; Trofa AF; Barrera-Oro M; Hyman T; Adams JM; Beattie DT; Killeen KP; Spriggs DR
    J Infect Dis; 1995 Oct; 172(4):1126-9. PubMed ID: 7561195
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenotypic and genetic characterization of Vibrio cholerae O1 isolated from various regions of Kenya between 2007 and 2010.
    Mercy N; Mohamed AA; Zipporah N; Chowdhury G; Pazhani GP; Ramamurthy T; Boga HI; Kariuki SM; Joseph O
    Pan Afr Med J; 2014; 19():8. PubMed ID: 25584121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
    Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
    Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.
    Saha A; Khan A; Salma U; Jahan N; Bhuiyan TR; Chowdhury F; Khan AI; Khanam F; Muruganandham S; Reddy Kandukuri S; Singh Dhingra M; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2016 Mar; 34(13):1551-1558. PubMed ID: 26896684
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intestinal and systemic immune responses in humans after oral immunization with a bivalent B subunit-O1/O139 whole cell cholera vaccine.
    Jertborn M; Svennerholm AM; Holmgren J
    Vaccine; 1996 Oct; 14(15):1459-65. PubMed ID: 8994322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins.
    Rui H; Ritchie JM; Bronson RT; Mekalanos JJ; Zhang Y; Waldor MK
    Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4359-64. PubMed ID: 20160087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxigenic
    Bhandari M; Rathnayake IU; Ariotti L; Heron B; Huygens F; Sullivan M; Jennison AV
    Appl Environ Microbiol; 2023 Oct; 89(10):e0047223. PubMed ID: 37800954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Method of DNA extraction and application of multiplex polymerase chain reaction to detect toxigenic Vibrio cholerae O1 and O139 from aquatic ecosystems.
    Rivera IN; Lipp EK; Gil A; Choopun N; Huq A; Colwell RR
    Environ Microbiol; 2003 Jul; 5(7):599-606. PubMed ID: 12823192
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholera vaccines.
    Ryan ET; Calderwood SB
    Clin Infect Dis; 2000 Aug; 31(2):561-5. PubMed ID: 10987721
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CVD110, an attenuated Vibrio cholerae O1 El Tor live oral vaccine strain.
    Michalski J; Galen JE; Fasano A; Kaper JB
    Infect Immun; 1993 Oct; 61(10):4462-8. PubMed ID: 8406837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Erratum: Eyestalk Ablation to Increase Ovarian Maturation in Mud Crabs.
    J Vis Exp; 2023 May; (195):. PubMed ID: 37235796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emergence of a new clone of toxigenic Vibrio cholerae O1 biotype El Tor displacing V. cholerae O139 Bengal in Bangladesh.
    Faruque SM; Ahmed KM; Abdul Alim AR; Qadri F; Siddique AK; Albert MJ
    J Clin Microbiol; 1997 Mar; 35(3):624-30. PubMed ID: 9041401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of a new ribotype of Vibrio cholerae O139 Bengal associated with an outbreak of cholera in Bangladesh.
    Faruque SM; Siddique AK; Saha MN; Asadulghani ; Rahman MM; Zaman K; Albert MJ; Sack DA; Sack RB
    J Clin Microbiol; 1999 May; 37(5):1313-8. PubMed ID: 10203477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Construction of a Vibrio cholerae prototype vaccine strain O395-N1-E1 which accumulates cell-associated cholera toxin B subunit.
    Rhie GE; Jung HM; Kim BS; Mekalanos JJ
    Vaccine; 2008 Oct; 26(43):5443-8. PubMed ID: 18582519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predicting Vibrio cholerae infection and symptomatic disease: a systems serology study.
    Wiens KE; Iyer AS; Bhuiyan TR; Lu LL; Cizmeci D; Gorman MJ; Yuan D; Becker RL; Ryan ET; Calderwood SB; LaRocque RC; Chowdhury F; Khan AI; Levine MM; Chen WH; Charles RC; Azman AS; Qadri F; Alter G; Harris JB
    Lancet Microbe; 2023 Apr; 4(4):e228-e235. PubMed ID: 36907197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.